-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...
More »SEARCH RESULT
IPR policy in the works
-The Telegraph New Delhi: The government plans to come out with a policy on intellectual property rights (IPR) within a few months, with developed nations such as the US and the EU raising concerns over the country's patent rules. "India does not have an IPR policy. This is the first time we are coming out with a policy. IPR policy issues have been hanging fire for quite a long time," commerce and...
More »Going for rotavirus -Vinod Paul
-The Hindu Business Line Battling childhood diarrhoea with an Indian vaccine is good strategy Almost half of India's 1,76,000 diarrhoeal deaths in children below five are caused by rotavirus, the pathogen responsible for severe childhood diarrhoea. In addition, 8 lakh hospitalisations and over 30 lakh outpatient visits each year among children below 5 are triggered by diarrhoea of rotavirus origin. WHO recommends the rotavirus vaccine for infants in all national immunisation programmes. Globally,...
More »The fast food bomb -Vandana Prasad
-The Hindu Obesity among children due to rampant consumption of junk food has reached epidemic proportions. With India already in the grip of this dangerous global trend, the government needs to remove its blinkers on the processed food industry One of the first declarations of the newly elected government in June was a proposal to ban unhealthy or junk food (defined as food high on fat, sugar and salt) in school...
More »Corruption in Indian Medicine Or ‘Overenthusiasm of the Marketing Department -Sanjay Nagral
-Economic and Political Weekly Corruption in Indian medicine is back on the front pages. One would think that there has been an abrupt spurt in corrupt practices or a major scandal. Nothing of that sort has happened. However, there have been some interesting developments for the focus to shift back to what is really a very old affliction. This is an update on recent happenings as the entrepreneurial spirit of the...
More »